<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="15" ids="28087">Glycogen</z:chebi> <z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">Storage Disease</z:e> Type I (GSD-I) is a <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> characterized by deficiency of <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphatase resulting in ineffective <z:chebi fb="15" ids="28087">glycogen</z:chebi> metabolism to <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>These patients frequently have <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, among many other metabolic derangements </plain></SENT>
<SENT sid="2" pm="."><plain>There is no consensus regarding the risk of developing <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We report an adult male with GSD-I who presented with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and a history of prior <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and multiple coronary stent placements </plain></SENT>
<SENT sid="4" pm="."><plain>We suggest that patients with GSD-I do have an increased risk of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and its complications and predict that these complications will be seen more frequently since patients with GSD-I are living longer as a result of better treatment </plain></SENT>
</text></document>